Research Article
The Adverse Effect of Spasticity on 3-Month Poststroke Outcome Using a Population-Based Model
Table 1
Characteristics of patients with and without spasticity.
| | No spasticity | Spasticity | value |
| Age at time of stroke | 68 | 25–93 | 59 | 29–89 | <0.001 |
| Black | 63 | 23.0 | 21 | 38.9 | 0.100 | Nonblack | 211 | 77.0 | 33 | 61.1 |
| Female | 134 | 48.9 | 25 | 46.3 | 0.767 | Male | 140 | 51.1 | 29 | 53.7 |
| Diabetes | 103 | 37.6 | 22 | 40.7 | 0.759 | Prior stroke | 56 | 20.4 | 17 | 31.5 | 0.106 | Severe periventricular white matter disease | 50 | 18.5 | 5 | 9.4 | 0.159 |
| Estimated NIHSS | 4.0 | 0–23 | 6.0 | 0–25 | 0.019 |
| Prestroke Rankin | 1.0 | 0–4 | 1.0 | 0–4 | 0.667 | Poststroke Rankin | 3.0 | 0–5 | 3.0 | 1–5 | 0.003 | 3-month Rankin | 2.0 | 0–5 | 3.0 | 1–5 | 0.000 |
|
|
Numbers are median and range or frequency and percent.
|